Key result
Sevoflurane preserved myocardial function better than propofol during MIDCAB surgery, as myocardial performance index worsened to 0.49 with propofol but remained unchanged with sevoflurane.
Why the study?
Does sevoflurane preserve myocardial function compared to propofol in patients undergoing minimally invasive direct coronary artery bypass surgery?
RCT (n=52)
Does sevoflurane preserve myocardial function compared to propofol in patients undergoing minimally invasive direct coronary artery bypass surgery?
Sevoflurane preserves myocardial function better than propofol during the brief period of ischemia in patients undergoing MIDCAB surgery.
Answers are grounded in this paper and cite their sources.
May support preferring sevoflurane over propofol for myocardial preservation in MIDCAB; extends RCT evidence on volatiles during brief ischemia.
Volatile anesthetics exert cardioprotective properties in experimental and clinical studies. We designed this study to investigate the effects of sevoflurane on left ventricular (LV) performance during minimally invasive direct coronary artery bypass grafting (MIDCAB) without cardiopulmonary bypass. Fifty-two patients scheduled for MIDCAB surgery were randomly assigned to a propofol or a sevoflurane group. Apart from the anesthetics used, there was no difference in surgical and anesthetic management. After determination of cardiac troponin T, creatine kinase, and creatine kinase MB, electrocardiographic (ECG) data and echocardiography variables (myocardial performance index and early to atrial filling velocity ratio) the left anterior descending coronary artery (LAD) was clamped until anastomosis with the left internal mammary artery was completed. During LAD occlusion and during reperfusion, echocardiography measurements were repeated. Blood samples were obtained repeatedly for up to 72 h. After LAD occlusion, myocardial performance index and early to atrial filling velocity ratio in the propofol group deteriorated significantly from 0.40 +/- 0.12 and 1.29 +/- 0.35 to 0.49 +/- 0.10 and 1.13 +/- 0.22, respectively, whereas there was no change in the sevoflurane group. In the propofol group myocardial performance index remained increased (0.47 +/- 0.11) compared with baseline during reperfusion. There were no significant differences in ECG and laboratory values between groups. In conclusion, during a brief period of ischemia in patients undergoing MIDCAB surgery, sevoflurane preserved myocardial function better than propofol.
No takes yet. Share an insight, caveat, or question.
Bein et al. (2005) conducted an RCT in Minimally invasive direct coronary artery bypass grafting (MIDCAB) (n=52). Sevoflurane vs. Propofol was evaluated on Left ventricular performance (myocardial performance index and early to atrial filling velocity ratio). Sevoflurane preserved myocardial function better than propofol during MIDCAB surgery, as myocardial performance index worsened to 0.49 with propofol but remained unchanged with sevoflurane.
Synapse has enriched 10 related papers. Consider them for comparative context: